A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Clinical trial NCT02478879 · COMPLETED

Trial details

NCT number: NCT02478879
Sponsor: Zosano Pharma Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2015-06-01
Primary completion: 2015-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.